Vedolizumab dose escalation as a way of recapturing response in patients with inflammatory bowel disease

被引：0
|
作者：
Sierra Morales, M. [1 ,2 ]
Birdi, S. [1 ]
Samaan, M. A. [1 ]
Brown-Clarke, C. [1 ]
Duncan, J. [1 ]
Stanton, A. [1 ]
Koumoutsos, I. [1 ]
Anderson, S. [1 ]
Ray, S. [1 ]
Mawdsley, J. [1 ]
Sanderson, J. [1 ]
Irving, P. M. [1 ]
机构：
[1] Guys & St Thomas NHS Fdn Trust, Dept Gastroenterol, London, England
[2] Hosp Univ Ramon & Cajal, Gastroenterol & Hepatol, Madrid, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P673
引用
收藏
页码：S451 / S452
页数：2
相关论文
共 50 条
  • [21] Vedolizumab trough concentrations are associated with endoscopic response in patients with inflammatory bowel disease
    Chao, C. -Y.
    Restellini, S.
    Lemieux, C.
    Germain, P.
    Bitton, A.
    Lakatos, P. L.
    Wild, G.
    Seidman, E.
    Bessissow, T.
    Afif, W.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S367 - S368
  • [22] THE EFFECT OF INFLIXIMAB DOSE ESCALATION IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH ANTIBODIES TO INFLIXIMAB
    Tun, Gloria S. Z.
    Marshall, Laura
    Thompson, Laura
    Campbell, Rebecca
    Hale, Melissa F.
    Chew, Thean S.
    Brooks, Alenka J.
    Robinson, Kerry
    Lobo, Alan J.
    [J]. GUT, 2019, 68 : A61 - A62
  • [23] The effect of infliximab dose escalation in inflammatory bowel disease patients with antibodies to infliximab
    Tun, Gloria S. Z.
    Robinson, Kerry
    Marshall, Laura
    Wright, Alison
    Thompson, Laura
    Wild, Graeme
    Sargur, Ravishankar
    Brooks, Alenka J.
    Hale, Melissa F.
    Chew, Thean S.
    Lobo, Alan J.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (03) : 295 - 301
  • [24] Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal response
    Samaan, Mark A.
    Birdi, Siddharth
    Morales, Maria Sierra
    Honap, Sailish
    Tamilarasan, Aravind Gokul
    Cunningham, Georgina
    Koumoutsos, Ioannis
    Ray, Shuvra
    Mawdsley, Joel
    Anderson, Simon H. C.
    Sanderson, Jeremy
    Irving, Peter M.
    [J]. FRONTLINE GASTROENTEROLOGY, 2020, 11 (03) : 188 - 193
  • [25] SAFETY OF VEDOLIZUMAB USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Shivashankar, Raina
    Ladd, Antonio H. Mendoza
    Grace, Rory
    Aberra, Faten
    Lichtenstein, Gary R.
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S585 - S585
  • [26] Vedolizumab Use in Pediatric Patients With Inflammatory Bowel Disease
    Singh, Namita
    Patel, Minesh
    Rabizadeh, Shervin
    Dubinsky, Marla
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S72 - S72
  • [27] De-escalation of biological therapy in inflammatory bowel disease patients following prior dose escalation
    Thomas, Pepijn W. A.
    Smits, Lisa J. T.
    Te Groen, Maarten
    West, Rachel L.
    Russel, Maurice G. V. M.
    Jansen, Jeroen M.
    Romkens, Tessa E. H.
    Hoentjen, Frank
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (05) : 488 - 495
  • [28] Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease
    Shmidt, Eugenia
    Kochhar, Gursimran
    Hartke, Justin
    Chilukuri, Prianka
    Meserve, Joseph
    Chaudrey, Khadija
    Koliani-Pace, Jenna L.
    Hirten, Robert
    Faleck, David
    Barocas, Morris
    Luo, Michelle
    Lasch, Karen
    Boland, Brigid S.
    Singh, Siddharth
    Vande Casteele, Niels
    Sagi, Sashidhar Varma
    Fischer, Monika
    Chang, Shannon
    Bohm, Matthew
    Lukin, Dana
    Sultan, Keith
    Swaminath, Arun
    Hudesman, David
    Gupta, Nitin
    Kane, Sunanda
    Loftus, Edward V., Jr.
    Sandborn, William J.
    Siegel, Corey A.
    Sands, Bruce E.
    Colombel, Jean-Frederic
    Shen, Bo
    Dulai, Parambir S.
    [J]. INFLAMMATORY BOWEL DISEASES, 2018, 24 (11) : 2461 - 2467
  • [29] Adalimumab Concentrations Following Dose Escalation in Inflammatory Bowel Disease
    Jasurda, Jake
    McCabe, Robert
    Vaughn, Byron
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S437 - S438
  • [30] OUTCOMES OF DOSE ESCALATION WITH ADALIMUMAB (ADA) IN INFLAMMATORY BOWEL DISEASE
    Dillon, A.
    Rowan, C.
    Gibson, D.
    Keegan, D.
    Byrne, K.
    Mulcahy, H.
    Cullen, G.
    Doherty, G.
    [J]. GUT, 2013, 62
12345